Intensive blood pressure lowering could benefit almost all adults with hypertensive chronic kidney disease

An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic blood pressure target of

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup